Publications in collaboration with researchers from Hospital de Gran Canaria Dr. Negrin (7)

2026

  1. Outcomes of Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis in Myelodysplastic Syndromes: A Multicenter Study Conducted on Behalf of GETH-TC

    Transplantation and Cellular Therapy, Vol. 32, Núm. 8, pp. 964.e1-964.e15

2025

  1. Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)

    Blood Cancer Journal, Vol. 15, Núm. 1

  2. Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC

    Frontiers in Immunology, Vol. 16

  3. Early cardiac events after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide. subanalysis exploring cardiac toxicity conducted on behalf of GETH-TC

    Frontiers in Immunology, Vol. 16

  4. Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation

    Cancers, Vol. 17, Núm. 19

2024

  1. Cardiac events after allo-HCT in patients with acute myeloid leukemia

    Blood Advances, Vol. 8, Núm. 21, pp. 5497-5509

  2. Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC

    Bone Marrow Transplantation, Vol. 59, Núm. 12, pp. 1694-1703